SCHEMBL7104686

SCHEMBL7104686

CC(CO)(CO)NCc1cnc(CNC(C)(CO)CO)cn1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.33
▸ TRPV3 Q8NET8 1/20 0.31
▸ CD274 Q9NZQ7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7656428 0.82 HTT (0.37) CYP1A2CD274
SCHEMBL7107275 0.80 LATS1 (0.33) TRPV3
SCHEMBL7105302 0.78 HTT (0.40) —
SCHEMBL7655866 0.72 HTT (0.34) CD274
SCHEMBL10246697 0.71 CYP1A2 (0.40) CYP1A2
SCHEMBL6132599 0.67 HTT (0.50) —
SCHEMBL4075711 0.63 — —
SCHEMBL13090073 0.62 HDAC3 (0.42) CYP1A2
SCHEMBL7103793 0.62 NUDT1 (0.33) —
SCHEMBL16476543 0.62 HTT (0.67) CYP1A2CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001944-B1 PYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM AVENTIS PHARMA SA (FR) 2003-10-01 — — EP claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 — — US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 — — US disclosed
Send feedback